Loading…
First Case of Staphylococci Carrying Linezolid Resistance Genes from Laryngological Infections in Poland
Linezolid is currently used to treat infections caused by multidrug-resistant Gram-positive cocci. Both linezolid-resistant (LRSA) and coagulase-negative staphylococci (CoNS) strains have been collected worldwide. Two isolates carrying linezolid resistance genes were recovered from laryngological pa...
Saved in:
Published in: | Pathogens (Basel) 2021-03, Vol.10 (3), p.335 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Linezolid is currently used to treat infections caused by multidrug-resistant Gram-positive cocci. Both linezolid-resistant
(LRSA) and coagulase-negative staphylococci (CoNS) strains have been collected worldwide. Two isolates carrying linezolid resistance genes were recovered from laryngological patients and characterized by determining their antimicrobial resistance patterns and using molecular methods such as
typing, MLST, SCC
typing, detection of virulence genes and
operon expression, and analysis of antimicrobial resistance determinants. Both isolates were multidrug resistant, including resistance to methicillin. The
strain was identified as ST-398/t4474/SCC
IVe, harboring adhesin, hemolysin genes, and the
operon. The
strain was identified as ST-42/
-positive and harbored hemolysin genes. Linezolid resistance in
strain was associated with the mutations in the ribosomal proteins L3 and L4, and in
, resistance was associated with the presence of
gene. Moreover,
strain harbored
and
genes. We identified the first case of staphylococci carrying linezolid resistance genes from patients with chronic sinusitis in Poland. Since both
and CoNS are the most common etiological factors in laryngological infections, monitoring of such infections combined with surveillance and infection prevention programs is important to decrease the number of linezolid-resistant staphylococcal strains. |
---|---|
ISSN: | 2076-0817 2076-0817 |
DOI: | 10.3390/pathogens10030335 |